Impeto Medical About Us
.
About Us
.
About Us
 
About Us
 

Impeto Medical devices: EZSCAN and SUDOSCAN

machine-1

machine-2

Impeto Medical

Our CEO, Philippe Brunswick, presents Impeto Medical on Worldwide Business with Kathy Ireland

Activation of the sweat glands to detect small fiber nerves neuropathy

 

Newscast: Impeto Medical News

 
About Us

2017 Events Calendar

2017 Events Calendar Diabetes French Society for Diabetes (Société Francophone du Diabète, SFD) - More here  March 28-31, 2017 - Lille, France ...
Read More
About Us

SUDOSCAN at the ALAD show in Bogota, 4-8 November 2016

SUDOSCAN was presented at the ALAD (Latin American Diabetes Association) show of 2016 in Bogota between 4 and 8 November ...
Read More
About Us

SUDOSCAN included in Polish Guidelines for the management of diabetic patients

Sudoscan in the "2016 Guidelines on the management of diabetic patients. A position of Diabetes Poland." (English excerpt of the ...
Read More

> Our Mission

Impeto Medical is a privately owned medical device company formed in June 2005. Its corporate headquarters are located in Paris, France. Two subsidiaries have been created: Beijing Impeto Medical in China and Impeto Medical Inc. in San Diego, U.S.

Our goal is to provide the medical community with screening tests to face epidemically spreading metabolic disorders and their complications. By providing less invasive, faster and less costly procedures, we enable physicians to screen larger patient populations and to detect diseases and complications earlier. We build value for our investors through constant innovation based on clinical research as well as focus on priority medical issues.

> Patents

The SUDOCAN® device is covered by following patents : "Electrophysiological analysis system and method" (Patent 1 898 783 and 2 124 736), and "Procédé d'analyse physiologique par stabilisation d'une surtension" (PCT2014/069479).